Can Buying Exelixis Stock Still Make You Rich?

What were you doing on Friday, Jan. 2, 2015? It's OK if you don't remember. I certainly can't.

But there were some investors who did something on that date who probably recall it with a smile. Anyone who bought shares of Exelixis (NASDAQ: EXEL) at the beginning of 2015 and held on to the stock are now sitting on a return of 1,560%. A $10,000 investment in the biotech less than three years ago would now be worth $166,000.

Exelixis has been one of the hottest biotech stocks in recent years. But can buying this stock still make you rich? It just might.

Source: Fool.com